Biomedical Advanced Research and Development Authority logo
BARDA Rapid Response Partnership Vehicle (RRPV)

BARDA RRPV — Member

Supports members of dedicated consortiums to pursue medical countermeasure proposals through BARDA rapid response partnership pathways.

OpenBiomedical Advanced Research and Development AuthorityUnited StatesDeep-tech · core fit

The BARDA RRPV (Rapid Response Partnership Vehicle) is an Other Transaction (OT) consortium managed by ATI (Advanced Technology International) on behalf of the Biomedical Advanced Research and Development Authority. The consortium issues Request for Project Proposals (RPPs) to member organizations for medical countermeasure development projects under non-FAR Other Transaction agreements. As of the most recent reporting, the consortium has awarded more than $809 million across its member companies, making it one of the largest MCM development vehicles in the federal government. OT agreements allow BARDA to move faster than standard FAR-based contracting and to engage non-traditional defense contractors more easily.

The three primary tracks within RRPV cover MedTech solutions, vaccines and therapeutics platforms, and MCM clinical research center capabilities. Eligible participants include for-profit companies, nonprofits, universities, and research organizations with U.S. operations; individual applicants are not eligible. Award amounts are set per individual RPP rather than published as a program-wide range — specific solicitations carry their own funding levels and technical requirements. Not all RRPV solicitations appear on SAM.gov; many RPPs are distributed exclusively within the member portal.

Membership in the RRPV consortium, applied for at rrpv.org, is a prerequisite before any organization can receive or respond to RPPs. The membership application is reviewed by ATI, and accepted members then gain access to the full RPP pipeline. Companies with early-stage MCM technologies looking to access BARDA funding outside the traditional grant or SBIR pathway should treat RRPV membership as the entry point. Once enrolled, members can respond to multiple RPPs across tracks, enabling a sustained development relationship with BARDA across successive project phases.

Medical countermeasure development projects issued as Request for Project Proposals to consortium members across MedTech, vaccines and therapeutics, and MCM clinical research center tracks via Other Transaction agreements.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Other Transaction (OT)
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Last verified: 29 Jun 2026Source: www.rrpv.org